Med. praxi. 2019;16(3):161-164 | DOI: 10.36290/med.2019.022

Armolipid Plus – a bridge between lifestyle changes and pharmacotherapy?

MUDr. Barbora Nussbaumerová, Ph.D.
Centrum preventivní kardiologie, II. interní klinika LF a FN v Plzni, UK v Praze

The nutraceutical Armolipid Plus includes substances of plant origin with a positive efect on lipid a glycide metabolism. This nutraceutical
was investigated in clinical studies and efficacy and tolerability was estimated. The current guidelines recommend this
nutraceutical as an aditive approach to healthy lifestyle in patients with low or moderate cardiovascular risk and with non-severe
dyslipidemia. Armolipid plus may be used in statin-intolerant or statin-not-willing patients.

Keywords: Armolipid Plus, nutraceuticals, dyslipidemia

Published: June 28, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nussbaumerová B. Armolipid Plus – a bridge between lifestyle changes and pharmacotherapy? Med. praxi. 2019;16(3):161-164. doi: 10.36290/med.2019.022.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. https://www.transparencymarketresearch.com/global-nutraceuticals-product-market.html.
    2. http://www.sukl.cz/leciva/rozliseni-doplnku-stravy-od-lecivych-pripravku.
    3. Collins R, Armitage J, Parish S, et al. [Heart Protection Study Collaborative Group]. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 2003; 361(9374): 2005-2016. Go to original source... Go to PubMed...
    4. Rosolová H. Mají doplňky stravy (nutriceuticals) svoje místo v ovlivnění dyslipidemií? Přípravek Armolipid Plus. AtheroRev 2017; 2(2): 143-146.
    5. Nussbaumerová B. Berberin. Acta medicinae 2018; 2-3: 56-60.
    6. Li Y, Huang T, Zheng Y, et al. Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2016; 5: e003768. Go to original source... Go to PubMed...
    7. Affuso F, Ruvolo A, Micillo F, et al. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis 2010; 20(9): 656-661. Go to original source... Go to PubMed...
    8. Pirro M, Del Giorno R, Lupattelli G, et al. Nutraceutical combination (red yeast rice, berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients. PharmaNutrition 2013; 1(2): 73-77. Go to original source...
    9. Ruscica M, Gomaraschi M, Mombelli G, et al. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus. J Clin Lipidol 2014; 8(1): 61-68. Go to original source... Go to PubMed...
    10. Sola R, Valls RM, Puzo J, et al. Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial. PLoS One 2014; 9(8): e101978. Go to original source... Go to PubMed...
    11. Gonnelli S, Caffarelli C, Stolakis K, et al. Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study. Curr Ther Res Clin Exp 2014; 77: 1-6. Go to original source... Go to PubMed...
    12. Pirro M, Mannarino MR, Bianconi V, et al. The effects of nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2016; 110: 76-88. Go to original source... Go to PubMed...
    13. Shang Q, Liu Z, Chen K, et al. A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia. HYPERLINK "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332166/" Evid Based Complement Alternat Med. 2012; 2012: 636547. Go to original source... Go to PubMed...
    14. Janský P, et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias: Summary of the document prepared by the Czech Society of Cardiology, Cor et Vasa 59 (2017) e389-e415. Dostupné z: http://www.sciencedirect.com/science/article/pii/S0010865017300371. Go to original source...
    15. Vrablík M, Piťha J, Bláha V. Nutraceutika s hypolipidemickým účinkem v klinické praxi: shrnutí stanoviska Mezinárodního expertního panelu lipidologů vypracované výborem České společnosti pro aterosklerózu. AtheroRev 2019; 4(1): 7-18.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.